Design of new inhibitors for CDC2 kinase based on a multiple pseudosubstrate structure

被引：15

作者：

Sasaki, S ^{[1
]}

Hashimoto, T

Obana, N

Yasuda, H

Uehara, Y

Maeda, A

机构：

[1] Kyushu Univ, Fac Pharmaceut Sci, Fukuoka 8128582, Japan

[2] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan

[3] Natl Inst Infect Dis, Tokyo 162, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 09期

关键词：

D O I：

10.1016/S0960-894X(98)00163-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac-Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：1019 / 1022

页数：4

共 20 条

[1] CELLULAR EFFECTS OF OLOMOUCINE, AN INHIBITOR OF CYCLIN-DEPENDENT KINASES [J].

ABRAHAM, RT ;

ACQUARONE, M ;

ANDERSEN, A ;

ASENSI, A ;

BELLE, R ;

BERGER, F ;

BERGOUNIOUX, C ;

BRUNN, G ;

BUQUETFAGOT, C ;

FAGOT, D ;

GLAB, N ;

GOUDEAU, H ;

GOUDEAU, M ;

GUERRIER, P ;

HOUGHTON, P ;

HENDRIKS, H ;

KLOAREG, B ;

LIPPAI, M ;

MARIE, D ;

MARO, B ;

MEIJER, L ;

MESTER, J ;

MULNERLORILLON, O ;

POULET, SA ;

SCHIERENBERG, E ;

SCHUTTE, B ;

VAULOT, D ;

VERLHAC, MH .

BIOLOGY OF THE CELL, 1995, 83 (2-3) :105-120

[2]

FUKUZAWA H, 1993, ANAL BIOCHEM, V212, P106

[3] OLOMOUCINE, AN INHIBITOR OF THE CDC2/CDK2 KINASES ACTIVITY, BLOCKS PLANT-CELLS AT THE G1 TO S AND G2 TO M CELL-CYCLE TRANSITIONS [J].

GLAB, N ;

LABIDI, B ;

QIN, LX ;

TREHIN, C ;

BERGOUNIOUX, C ;

MEIJER, L .

FEBS LETTERS, 1994, 353 (02) :207-211

[4] A myristoylated pseudosubstrate peptide inhibitor of protein kinase C: Effects on glucose- and carbachol-induced insulin secretion [J].

Harris, TE ;

Persaud, SJ ;

Saermark, T ;

Jones, PM .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 121 (02) :133-141

[5] GROWTH-INHIBITION WITH REVERSIBLE CELL-CYCLE ARREST OF CARCINOMA-CELLS BY FLAVONE-L86-8275 [J].

KAUR, G ;

STETLERSTEVENSON, M ;

SEBERS, S ;

WORLAND, P ;

SEDLACEK, H ;

MYERS, C ;

CZECH, J ;

NAIK, R ;

SAUSVILLE, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (22) :1736-1740

[6]

KITAGAWA M, 1994, ONCOGENE, V9, P2549

[7]

KITAGAWA M, 1993, ONCOGENE, V8, P2425

[8]

LI PM, 1993, ANTICANCER RES, V13, P1957

[9] POTENT INHIBITION OF CDC2 KINASE-ACTIVITY BY THE FLAVONOID L86-8275 [J].

LOSIEWICZ, MD ;

CARLSON, BA ;

KAUR, G ;

SAUSVILLE, EA ;

WORLAND, PJ .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (02) :589-595

[10]

Meijer L, 1997, METHOD ENZYMOL, V283, P113

← 1 2 →